Explore Global Companies & Account Intelligence

Creating a Drug Free Workplace is something we feel passionate about because whether you are an employer or employee, both work life and home life is significantly improved when you part of a Drug Free Business. As a non-profit 501(c)(3) organization formed in 1988, we've been guiding employers, both large and small, on how to start and maintain a drug-free workplace as this results in greater safety, increased productivity, lower benefit costs, improved profits and employee retention and client satisfaction. We provide DOT consortium services, Clean Card Programs and third-party administration (C-TPA) of drug testing companies nationwide. Many employer and union associations recommend us to their members. We are one of only three Certified Third-Party Administrators by the Substance Abuse Program Administrators Association (SAPAA) and many of our employees have the prestigious Substance Abuse Program Administrators certification (CSAPA). Drug Free Business provides your company with everything you need to achieve a comprehensive drug-free workplace program, and/or comply with Department of Transportation (DOT) or state mandated marijuana testing regulations, including policy development, employee and supervisor training, drug and alcohol testing, random selection services, and Substance Abuse Professional (SAP) referrals for testing your safety-sensitive workers. Our professional and welcoming client service team will get your account set up quickly and efficiently and our in-house accredited and certified Medical (MRO) department reviews accurately and quickly provides drug test results over our secure and confidential web portal to our clients 24/7 for fast on-boarding of your new hires. And whether you need oral fluid or standard lab drug or alcohol testing locally or across the country, mobile testing at the worksite or at a clinic or patient service center, Drug Free Business has got you covered.

DRIVEs Leadership has discovered and advanced the development of some of the worlds most successful and valuable antiviral drugs. DRIVE combines these seasoned leaders with over $20M in foundational funding from Emory University to build a world class infrastructure for developing drugs for viral diseases of global concern. We invite you to join with us in our urgent quest to develop valuable and critically needed drugs to fight against these viral

Aim Our aim is to achieve the highest possible scientific and ethical standards, by putting the interests of patients first and to work with integrity and fairness with all our partners. Risk management Through our historical links with doctors in the NHS, the unit conducts studies in both primary and secondary care, many of which are risk management studies which are part of Risk Management Plans (RMPs) in the EU. Pharmacovigilance Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes all forms of research studies and evaluations of the safety of medicines and provides education and training in pharmacovigilance and related subjects. Independent Scientific Excellence The DSRU is an independent unit providing scientific excellence demonstrated through conducting studies which are used to support public health decisions and production of publications in international peer reviewed journals since 1980. The DSRU makes significant, valuable contributions in the area of post marketing surveillance of pharmaceutical products. We have achieved both recognition and endorsement by the regulatory authorities, healthcare professionals and pharmaceutical industry worldwide.

Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is the President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com

Drugdevs

Comprehensive enterprise dossier available in global intelligence registry.

Drugs & Diagnostics for Tropical Diseases (DDTD) is a unique non-profit (501c3) venture based in San Diego, CA, with a mission “to discover new treatments and diagnostics for neglected tropical diseases”. These diseases have been typically neglected from research and development efforts due to the perceived lack of profitability and are commonly referred to as Neglected Tropical Diseases or NTDs. As part of our mission, we are developing easy to use, rapid, inexpensive diagnostics to specifically detect infections associated with loiasis, lymphatic filariasis, and river blindness. We are passionate about serving the needs of the underprivileged within our capacity as scientists. In addition, we believe it is important to increase public awareness of the dire need to improve global health. The community’s resulting civic engagement can make an impact globally and DDTD wants to lead these efforts. At an international level, DDTD embraces the idea of eliminating diseases that do not belong in the 21st century. The first step towards eliminating a disease is the ability to detect it. Mapping diseases is critical for the World Health Organization (WHO) and its affiliates to initiate mass drug administration programs, allocate resources, monitor progress, and eventually verify elimination. DDTD focuses on Neglected Tropical Diseases (NTDs), a group of diseases that afflicts 1 in 6 people, or approximately 1.4 billion individuals worldwide. NTDs are severely debilitating, lower cognitive function in children, and hamper economic development. Worldwide, 149 countries and territories are affected by at least one NTD, resulting in approximately 57 million years of life lost due to premature disability. At a domestic level, we seek to reduce health inequity within local communities by providing a portfolio of low-cost rapid diagnostic tests (RDTs) developed specifically for homeless individuals and people living in precarious conditions.

DrugSmart Pharmacy is a group of independently-owned pharmacies driven to provide its customers with the highest level of service and care. We are a rapidly growing company with a diverse portfolio in the healthcare industry, leveraging our ability to adapt to unique opportunities and niche markets. We have a strong focus on developing new and innovative concepts in our field and staying on top of emerging trends.

The DrugStars ecosystem comprises the scientifically validated DrugStars medication app, the DrugsDisclosed.com our SaaS platform for patients, pharmaceutical companies and payers alike. DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences from real-world patients. DrugsDisclosed.com collates data from 430,000 patient reviews from global users of the DrugStars medication app, launched by Claus Møldrup in 2017. The service has over 55 million unique data points around medication reviews. It provides anonymous secondary market patient insights for specific medications and conditions. DrugStars is committed to empowering patients. The company donates 20% of its revenues to over 240 global patient organizations and enables the users to earn donations for their chosen organization. To date, DrugStars has donated £376,835 to patient organisations around the world.

A Modern Golf Apparel & Accessories Brand.

Druid is a technology company established in 1998 focusing on the development and integration of complex, high performance, and scalable systems. Since 2016 we are focusing on enabling our clients to overcome the limitations of traditional on-premise business applications and unlock the power and flexibility of Cloud. Druid’s team of experts provides support to help companies migrate and modernize applications to the AWS by re-designing an architecture that enables greater agility, speed, innovation, and better application capabilities for application development and enhancement. Increase Innovation when experimentation is Fast and Low Risk!

We consult, build and further develop. Our passion is making high-performance, long-lasting and functional digital solutions that help our clients reach their business goals. Our roots are in Drupal development and we also use other open source technologies according to each customer's needs. Druid is founded by developers, for developers. We want to be the best workplace for developers, make clients happy and work on agile projects that would make the digital world a better place to be.